相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-148-3p and miR-152-3p synergistically regulate prostate cancer progression via repressing KLF4
Feng Feng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Antagonistic activities of miR-148a and DNMT1: Ectopic expression of miR-148a impairs DNMT1 mRNA and dwindle cell proliferation and survival
Dipta Sengupta et al.
GENE (2018)
Up-regulated miR-29c inhibits cell proliferation and glycolysis by inhibiting SLC2A3 expression in prostate cancer
Junliang Li et al.
GENE (2018)
Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas
Elham Kalantari et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth
P. H. Nguyen et al.
ONCOGENE (2016)
DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis
Eunsohl Lee et al.
NEOPLASIA (2016)
Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer
Michal Podrazil et al.
ONCOTARGET (2015)
Mir-152 inhibits cell proliferation and colony formation of CD133+ liver cancer stem cells by targeting KIT
Haili Huang et al.
TUMOR BIOLOGY (2015)
MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells
Riccardo Di Fiore et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment
Roisin M. Connolly et al.
CLINICAL CANCER RESEARCH (2013)
miR-29 Represses the Activities of DNA Methyltransferases and DNA Demethylases
Sumiyo Morita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression
Roberta Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines
Chen Zhu et al.
PROSTATE (2013)
Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells
A. R. Bernardo et al.
CELL DEATH & DISEASE (2013)
The Use of Retinoids in Ovarian Cancer A Review of the Literature
Jenny M. Whitworth et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence
Salome Gonzalez-Reyes et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Retinoid pathway and cancer therapeutics
Nathan Bushue et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Arsenic Exposure Transforms Human Epithelial Stem/Progenitor Cells into a Cancer Stem-like Phenotype
Erik J. Tokar et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
TLR Stimulation of Prostate Tumor Cells Induces Chemokine-Mediated Recruitment of Specific Immune Cell Types
Roberta Galli et al.
JOURNAL OF IMMUNOLOGY (2010)
Arsenic-Specific Stem Cell Selection During Malignant Transformation
Erik J. Tokar et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1
Te Liu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
DNMT1 Silencing Affects Locus Specific DNA Methylation and Increases Prostate Cancer Derived PC3 Cell Invasiveness
Ahmed Yaqinuddin et al.
JOURNAL OF UROLOGY (2009)
Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-α-dependent mechanism
Alessio Paone et al.
CARCINOGENESIS (2008)
Inorganic arsenic and human prostate cancer
Lamia Benbrahim-Tallaa et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2008)
Tumor-suppressive activity of retinoic acid receptor-β in cancer
Xiao-Chun Xu
CANCER LETTERS (2007)
Natural and synthetic retinoids in prostate cancer
D. Pasquali et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
All-trans-retinoic acid and polyriboinosinic:: polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity
KL Decicco et al.
IMMUNOLOGY (2001)
分享论文
